Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioluminescence-based assays for quantifying endogenous protein interactions in live cells.

The Journal of biological chemistry·2025
Same author

A Nondestructive, Real-Time Annexin V Apoptosis Assay.

Methods in molecular biology (Clifton, N.J.)·2022
Same author

Treating Cells as Reagents to Design Reproducible Assays.

SLAS discovery : advancing life sciences R & D·2021
Same author

A live-cell assay for the real-time assessment of extracellular ATP levels.

Analytical biochemistry·2021
Same author

A Real-Time, Bioluminescent Apoptosis Assay.

Methods in molecular biology (Clifton, N.J.)·2021
Same author

Target engagement and drug residence time can be observed in living cells with BRET.

Nature communications·2015

Related Experiment Video

Updated: Jun 16, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput

Andrew L Niles1, Richard A Moravec, Terry L Riss

  • 1Research Department, Promega Corporation, 2800 Woods Hollow Road, Madison, WI, USA. andrew.niles@promega.com

Current Chemical Genomics
|February 18, 2010
PubMed
Summary

In vitro cytotoxicity testing aids drug discovery by assessing toxic potential. This review highlights robust high-throughput screening (HTS) assays for efficient cytotoxic risk evaluation in new chemical entities.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

Related Experiment Videos

Last Updated: Jun 16, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Discovery

Background:

  • In vitro cytotoxicity testing is crucial for drug discovery, offering cost-effective and predictive characterization of new chemical entities' toxic potential.
  • Early implementation of cytotoxicity assays is vital for human health prognostication.
  • While numerous 96-well assays exist, few are suitable for high-throughput screening (HTS) due to practicality and sensitivity limitations.

Purpose of the Study:

  • To review robust and validated HTS assays for efficient cytotoxic risk assessment.
  • To provide guidance for successful HTS implementation.
  • To discuss the advantages of combining HTS-compatible assays in multi-parametric, same-well formats.

Main Methods:

  • Review of established HTS cytotoxicity assays.
  • Discussion of assay validation and implementation strategies.
  • Analysis of multi-parametric, same-well assay formats.

Main Results:

  • Identification of robust and validated HTS assays for cytotoxic risk assessment.
  • Guidance provided for effective HTS implementation.
  • Discussion of the benefits and drawbacks of various HTS methods.

Conclusions:

  • Selected HTS assays offer accurate and efficient means to assess cytotoxic risk in drug discovery.
  • Strategic implementation and combination of assays can enhance predictive power.
  • Further development in multi-parametric HTS assays is beneficial for comprehensive toxicological profiling.